Lung Inflammation Reducer

Roflumilast

Daily oral therapy to reduce inflammation and prevent COPD exacerbations.

Roflumilast is a selective phosphodiesterase-4 (PDE4) inhibitor prescribed to reduce the risk of COPD exacerbations in patients with severe chronic obstructive pulmonary disease associated with chronic bronchitis. It works by targeting inflammation in the lungs, improving airflow, and decreasing the frequency of flare-ups that worsen breathing difficulties and overall lung health.

Ingredients dosages:

Frequency:

Quantity:

Not sure about dosages? Don't worry, your provider will adjust or confirm your selection after checkout.

Total

$0.00

Here's what happens next:

  1. 1

    Product checkout

    We'll direct you to our product detail page where you can start the checkout process. You'll be charged for the medical consultation but the medication charge is a hold until the official provider review.

  2. 2

    Comprehensive Medical Questionnaire

    After purchase, you'll be directed to a medical assessment covering your medical history, current medications, and specific symptoms.

  3. 3

    Licensed Provider Review

    A licensed healthcare provider reviews your complete medical profile, ensuring this treatment is safe and appropriate for you.

  4. 4

    Personalized Treatment Plan

    Your provider may recommend an adjustment to your prescription based on your full medical profile before approving your treatment.

HIPAA Compliant
Certified Providers

  • Significantly reduces the frequency of moderate to severe COPD exacerbations

  • Improves lung function (FEV1) by reducing airway inflammation

  • Enhances overall respiratory health and symptom stability

  • Lowers systemic inflammation markers linked to COPD progression

  • Supports reduced hospitalizations due to fewer exacerbation episodes

  • Roflumilast: A PDE4 inhibitor that increases intracellular cAMP levels, reducing the activity of inflammatory cells and mediators in the lungs, resulting in decreased inflammation and improved breathing in COPD patients